This year, Avoca's research focuses on understanding industry actions toward adoption of ICH E6(R3), as well as impact on clinical trial design and execution, to foster collaboration and successful implementation.
Access The 2025 Avoca State of the Industry Report:
Understanding Adoption & Implementation of ICH E6(R3)
March 13, 2026 | 11:00am – 12:00pm EST
Held the second Friday of every month and open to the industry, this webinar offers a live demonstration of the AQC Knowledge Center.
January 22, 2026 | 11:00am – 12:00pm EST
Monthly forum open exclusively to Avoca Quality Consortium members.
October 20-24, 2025 | Virtual
Join the AQC's Michelle Webb and Karen Harvey for the session: "Preparing Clinical Trial Sites for ICH E6(R3): Practical Guidance for Investigators"
July 9, 2025 | 11:00am – 12:00pm EDT
Join us for an exclusive webinar unveiling the key findings from the 2025 Avoca Industry Report, which focuses on the industry’s readiness and response to the upcoming ICH E6(R3) mandate.
In the intricate tapestry of clinical trials, collaboration ensures quality and streamlines processes vital for advancing medical science and discovering new treatments. The recent update to the ICH E6(R3) guidance features collaboration as the invisible thread that is seamlessly woven throughout the key changes [...]
Read MoreArtificial Intelligence solutions in clinical trials are only as good as the data they process. With a focus on quality, AI can be harnessed to drive research forward. Understanding the intricacies of [...]
Read More